New Products

NEW YORK — Music artist Pitbull has announced the launch of new scents for men and women, Pitbull Premier Fragrances, which will be available exclusively on Amazon.com beginning Dec. 1.

This new venture by Pitbull urges consumers to "Unlock the World" through scent. Inspired by taking a trip around the world, these fragrances embody the electric energy of each city and its nightlife.

DUBLIN — Drug maker Actavis hopes to become the first to market with a generic version of a topical testosterone replacement drug marketed by Eli Lilly, Actavis said.

The generic drug maker it filed with the Food and Drug Administration for approval of testosterone topical solution in the 30-mg-per-1.5 mL strength, a generic version of Lilly's Axiron. The drug is used as a replacement therapy for deficient or absent testosterone.

PITTSBURGH — Generic drug maker Mylan has launched its version of a drug for treating attention deficit hyperactivity disorder, the company said Monday.

Mylan announced the launch of dexmethylphenidate hydrochloride extended-release capsules in the 30-mg strength, a generic version of Novartis' Focalin XR. As the first company to win approval for a generic version of the drug, Mylan has 180 days in which to compete exclusively against Novartis' product.

ENTERPRISE, Utah — Southern Utah startup company, Finger Candy Nail Art, is aiming to take the nail care industry by storm with its nail art products. While the company won’t officially launch until early 2014, it is encouraging independent distributors to now sign up.

NEW YORK — A bill that would implement federal tracking and tracing of drugs and strengthen federal regulations on pharmacy compounding has passed in the Senate and will go to President Barack Obama for his signature.

NEW YORK — Looking to help keep babies’ teeth and gums healthy, dental care industry professional and mother of three, Kasey Pitillo, has created Happy Teeth, a line of gentle and natural dental products.

LAVAL, Quebec — The Food and Drug Administration has approved a new drug for fungal infections of the skin made by Valeant Pharmaceuticals International, the drug maker said Friday.

The company announced the FDA approval of Luzu (luliconazole) cream in the 1% strength for treatment of athlete's foot, jock itch and ringworm in adults.

WASHINGTON — A Food and Drug Administration expert panel has voted to recommend approval for a drug to treat a circadian rhythm disorder that affects most people with total blindness.